Taysha Gene Therapies Inc (TSHA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Operating Expenses | 32,090 | 18,367 | 15,041 | 4,010 | 5,584 |
| Operating Income | -32,090 | -18,367 | -15,041 | -4,010 | -5,584 |
| Interest Expense | 0 | 0 | 1 | 0 | 27 |
| Other Income | 66 | 49 | 0 | -17,210 | 180 |
| Pre-tax Income | -32,024 | -18,318 | -15,042 | -21,220 | -5,431 |
| Net Income Continuous | -32,024 | -18,318 | -15,042 | -21,220 | -5,431 |
| Net Income | $-32,024 | $-18,318 | $-15,042 | $-21,220 | $-5,431 |
| EPS Basic Total Ops | -0.87 | 0.33 | -1.28 | -1.95 | -0.50 |
| EPS Basic Continuous Ops | -0.87 | 0.33 | -1.28 | -1.95 | -0.50 |
| EPS Diluted Total Ops | -0.87 | 0.33 | -1.28 | -1.95 | -0.50 |
| EPS Diluted Continuous Ops | -0.87 | 0.33 | -1.28 | -1.95 | -0.50 |
| EBITDA(a) | $-32,058 | $-18,361 | $-15,041 | $-4,010 | $-5,584 |